Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production
Condition: Adrenocortical Carcinoma Interventions: Drug: Relacorilant; Drug: Pembrolizumab Sponsor: Corcept Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials